Integra LifeSciences Holdings Corporation

NASDAQ:IART

Medical - Devices

Healthcare
$13.86 +4.71%

+$0.81 today

Market cap
$1.08B
Beta
1.25
P/E (TTM)
-2.8
EPS (TTM)
-$6.44
52W Low $8.70High $18.26

Volume 0.58M

Average 0.96M

IART Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Integra LifeSciences Holdings CorporationNASDAQ: IART

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses declines year over year

Q1 FY2026 operating expenses of $184.15M fell 12.3% year over year, in line with the -12.7% change in trailing-twelve-month operating expenses. Over 3 fiscal years it compounded at +2.0% a year.

Context

  • Operating expenses amounted to 47.5% of revenue in FY2025, down 5.5 pp from a year earlier.
  • Operating expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -12.3% holds above the trailing-twelve-month pace of -12.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$184.15M+154.0% QoQ
Last fiscal yearDec 2025
$776.92M-9.0% YoY
LTMMar 2026
$751.14M-12.7% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.3%——
1 year-9.0%——
3-year CAGR+2.0%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
776.92M USD
Year-over-year change
-9.0%
4-year CAGR
+1.0%

Operating Expenses vs competitors

How IART compares with its peers on the latest reported figures

  • IART's LTM Mar 2026 operating expenses of $751.14M is the 4th highest of the 11 companies compared; the peer median is $576.21M.
  • Its year-over-year change of -12.7% is the lowest of 11, against a peer median of +2.8%.
  • Operating expenses amounts to 45.7% of revenue for IART, versus a peer median of 57.5%.
IART Competitors Peer median
Operating Expenses for IART and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$11.15B +13.6%+15.2%43.1%
SNNSmith & Nephew plcFY2025$3.41B -0.3%+1.6%55.4%
GMEDGlobus Medical, Inc.LTM Jun 2026$1.5B +10.1%+41.4%47.8%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$751.14M -12.7%+2.0%45.7%
OFIXOrthofix Medical Inc.LTM Mar 2026$602.92M -6.4%+21.0%73.0%
CNMDCONMED CorporationLTM Mar 2026$581.85M +5.4%+5.2%42.4%
ATECAlphatec Holdings, Inc.LTM Mar 2026$570.57M -1.6%+17.3%72.5%
AORTArtivion, Inc.LTM Mar 2026$253.12M +8.3%+7.5%55.2%
AXGNAxoGen, Inc.LTM Sep 2026$211.81M +35.3%+8.1%79.4%
TELATELA Bio, Inc.LTM Jun 2026$88.2M +0.3%+10.1%110.4%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$72.7M -7.6%+25.6%59.6%
Peer median (excluding IART) $576.21M+2.8%+12.6%57.5%

Competitors are the stored peer set for IART. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.54B1.56B1.54B1.61B1.64B
Cost of Revenue597.81M587.36M656.84M728.47M790.01M
Gross Profit944.64M970.31M884.74M882.06M845.23M
Gross Margin61.2%62.3%57.4%54.8%51.7%
Research & Development93.05M101.19M104.19M115.38M98.97M
Selling, General & Admin637.45M616.32M656.64M716.98M699.7M
Operating Expenses747.41M731.39M773.21M853.65M776.92M
Depreciation & Amortization123.67M121.12M123.51M140.5M151.05M
EBITDA366.33M384.6M255.96M193.29M(326.2M)
EBITDA Margin23.7%24.7%16.6%12.0%-19.9%
Operating Income197.23M238.92M111.53M28.41M68.32M
Operating Margin12.8%15.3%7.2%1.8%4.2%
Interest Income6.74M11.92M17.2M20.04M18.47M
Interest Expense50.4M49.59M51.38M70.63M86.26M
Other Income / Expenses17.45M(25.03M)(30.46M)(46.65M)(631.82M)
Income Before Tax214.68M213.89M81.07M(18.24M)(563.5M)
Pre-Tax Margin13.9%13.7%5.3%-1.1%-34.5%
Income Tax Expense45.6M33.34M13.33M(11.29M)(47.03M)
Net Income169.08M180.55M67.74M(6.94M)(516.47M)
Net Margin11.0%11.6%4.4%-0.4%-31.6%
EPS (Basic)2.002.180.87(0.09)(6.73)
EPS (Diluted)1.982.160.84(0.09)(6.73)
Weighted Avg Shares84.7M83M78.17M77.01M76.75M
Weighted Avg Shares (Diluted)85.49M83.52M80.34M77.01M76.75M

Integra LifeSciences Holdings Corporation

NASDAQ:IART

Intrinsic Alpha fair value

Locked

Current Price

$13.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.